If you missed the opportunity to make fifty times your money on internet stocks or Bitcoin you’re still in luck. There is new opportunities that lies in investing in Cannabis and Biotech firms right now.
Perhaps the most important part of choosing investments is determining how much risk you can take on. Ultra-risky stocks often have the potential to deliver impressive pay-days while safe, tried-and-true investments tend not to raise eyebrows with their gains. If you’re willing to take on a high degree of risk, there’s no shortage of investment choices out there.
One undiscovered company that has caught our attention is BRTX (BioRestorative Therapies, Inc.). Start doing your own research on BRTX right now. BRTX is currently preparing for its phase 2 clinical trial using BRTX-100. Anyone that discovers BRTX before the phase 2 clinical trial begins could be in store for a great run.
These Cannabis and Technology Stocks Should Be Watched: BioRestorative Therapies, Inc. (OTCQB: BRTX), CV Sciences, Inc. (OTCQB: CVSI), Synchronoss Technologies, Inc. (OTCPINK: SNCR), Bitcoin Investment Trust (OTCQX: GBTC), Aurora Cannabis Inc. (OTCQX: ACBFF).
BioRestorative Therapies, Inc. (OTCQB: BRTX)
Market Cap: $14.82M, current share price: $2.23
BioRestorative Therapies, Inc. develops therapeutic products using cell and tissue protocols, primarily involving adult stem cells. Their lead cell therapy candidate, BRTX-100, is a product formulated from autologous (person’s own) cultured mesenchymal stem cells collected from bone marrow. They intend the product will be used for the non-surgical treatment of painful lumbosacral disc disorders. The treatment is intended for patients whose pain has not been alleviated by non-invasive procedures and who potentially face the prospect of surgery. They have received clearance from the Food and Drug Administration to commence a Phase 2 clinical trial using BRTX-100. In addition, their metabolic program (ThermoStem®) is developing a cell-based therapy to target obesity, diabetes and other metabolic disorders using brown adipose (fat) derived stem cells to generate brown adipose tissue.
CV Sciences, Inc. (OTCQB: CVSI)
Market Cap: $248.25M, current share price: $2.95
CV Sciences, Inc. is a life science company that operates through two segments, specialty pharmaceuticals and consumer products. The Company focuses on developing and commercializing proprietary prescription drugs utilizing synthetic cannabidiol (CBD) as the active pharmaceutical ingredient and is engaged in the development, manufacturing, marketing and sale of consumer products containing plant-based CBD, which is refined into its own proprietary branded products. CV Sciences initial drug candidate (CVSI-007) is a chewing gum that combines CBD and nicotine, which the Company believes has the potential to effectively treat smokeless tobacco use and addiction.
Synchronoss Technologies, Inc. (OTCPINK: SNCR)
Market Cap: $227.72M, current share price: $4.06
Synchronoss transforms the way companies create new revenue, reduce costs and delight their subscribers with cloud, messaging, digital and IoT products, supporting hundreds of millions of subscribers across the globe. Synchronoss’ secure, scalable and groundbreaking new technologies, trusted partnerships and talented people change the way TMT customers grow their business.
Bitcoin Investment Trust (OTCQX: GBTC)
Market Cap: $2B, current share price: $11.49
Bitcoin Investment Trust is a private, open-ended trust that invests exclusively in bitcoin and derives its value solely from the price of bitcoin. It enables investors to gain exposure to the price movement of bitcoin without the challenge of buying, storing, and safekeeping bitcoins.
Aurora Cannabis Inc. (OTCQX: ACBFF)
Market Cap: $3B, current share price: $5.18
Aurora Cannabis Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR). In addition, the Company holds approximately 9.6% of the issued shares (12.9% on a fully-diluted basis) in a leading extraction technology company, Radient Technologies Inc., based in Edmonton, and is in the process of completing an investment in Edmonton-based Hempco Food and Fiber Inc. for an ownership stake exceeding 50.0%.
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. ACR Communication, LLC, which owns Microcapspeculators.com, is not registered with Finra or any other financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. ACR Communication, LLC [and/or] Microcapspeculators.com does not have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. ACR Communication LLC, which owns Microcapspeculators.com, is compensated for its services in the form of cash-based compensation or in equity in the companies it writes about, or a combination of the two. ACR Communication, LLC has been compensated one thousand dollars cash for this article and eight thousand dollars total by Regal Consulting, LLC, for BRTX. BRTX and Regal Consulting, LLC were given an opportunity to edit information included in this article. This article is based solely on public information and the opinions of ACR Communication, LLC, which believes the news commentary to include accurate and complete information. ACR Communication, LLC, will not buy or sell any shares in stocks contained within this article for forty eight hours after this article’s distribution.
For Full Legal Disclaimer Click Here.
Company Name: Microcap Speculators
Contact Person: Media Manager
Country: United States